Clinical trial
Famotidine Compared With Esomeprazole in the Prevention of Ulcer Complications in Patients With Acute Coronary Syndrome or Myocardial Infarction
NCT00683111 is registered in ClinicalTrials.gov with Ruttonjee Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Famotidine Compared With Esomeprazole in the Prevention of Ulcer Complications in Patients With Acute Coronary Syndrome or Myocardial Infarction
- Lead sponsor
- Ruttonjee Hospital
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- July 31, 2008
- Completion date
- December 31, 2011
- Enrollment
- 500 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acute coronary syndrome, acute myocardial infarction